ioneer IONR 深 滬
等待開盤 07-06 09:30:00 美东时间
4.40
-0.010
-0.23%
華盛通- 最 高4.58
- 今 開4.39
- 成交量 12.78万股
- 最 低 4.323
- 昨 收 4.41
- 總市值 3.34亿
- 52周最高 8.20
- 市盈率 靜 --
- 換手率 0.17%
- 52周最低 2.64
- 委 比 75.85%
- 總股本 7582.78万
- 歷史最高 24.00
- 量 比 0.58
- 振 幅 5.83%
- 歷史最低 2.30
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ioneer Updates Bernard Rowe’s Equity Holdings After Performance Rights Conversion
ioneer Limited ( ($AU:INR) ) has issued an announcement. Ioneer Ltd has disclos...
今天 08:47
UPDATE 1-Kioxia ships next-gen memory samples as AI boom fuels dramatic comeback
UPDATE 1-Kioxia ships next-gen memory samples as AI boom fuels dramatic comeback NAND maker has become beneficiary of AI boom Kioxia has developed next-generation memory with Sandisk Japan aims to rebuild its once-mighty chip industry Chipmaker's shares volatile in recent days Adds market context in
07-03 14:44
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology granted inducement stock options to five new employees on July 1, 2026, under its 2023 Inducement Option Plan. The options, totaling 68,750 shares with an exercise price of $10.78 per share, vest over four years, with 25% vesting after one year and the remainder vesting monthly over the next 36 months. The grant aligns with Nasdaq Listing Rule 5635(c)(4) and is subject to the terms of the Company’s option plan and agreements.
07-03 11:30
Ioneer performance rights lapse after vesting conditions unmet
ioneer Limited ( ($AU:INR) ) has shared an update. Ioneer Ltd has notified the ...
07-03 08:57
Terra Innovatum Appoints Smart Wires CEO Joanna Lohkamp as Independent Director
Terra Innovatum appoints Joanna Lohkamp, CEO of Smart Wires, to its Board of Directors. With over 30 years of leadership experience, Lohkamp brings expertise in board governance, technology, and infrastructure. Terra Innovatum is advancing NRC licensing, deployment of its SOLO™ micro-modular reactor, and commercialization efforts. SOLO™ provides scalable, safe, and carbon-free energy solutions for various applications, including remote power and ...
07-02 21:45
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
CapsoVision appoints David S. Shields, M.D., a leading gastroenterologist with over 40 years of experience, to its Board of Directors. Dr. Shields, a pioneer in capsule endoscopy, succeeds Joanne C. Imperial, M.D., who continues as a clinical consultant. CapsoVision is advancing its AI-enabled capsule endoscopy platform, including the upcoming launch of an AI-assisted reading feature for CapsoCam Plus® and development of CapsoCam Colon™.
07-02 20:05
Profusa Announces 1-for-25 Reverse Stock Split
Profusa, Inc. announced a 1:25 reverse stock split of its common stock, effective July 7, 2026. This will reduce the number of outstanding shares from approximately 13.2 million to about 530,000. The common stock will continue trading under the ticker symbol "PFSA" with a new CUSIP number. Fractional shares will be settled in cash. The company, based in Berkeley, California, specializes in digital health technologies for continuous biochemical mo...
07-02 15:00
Cartesian Therapeutics Announces New Employment Inducement Grants
Cartesian Therapeutics granted inducement stock options to eight new employees on July 1, 2026, totaling 238,700 shares with an exercise price of $10.18. The options vest over four years, with 25% vesting on July 1, 2027, and the remaining vesting in monthly installments until full vesting on July 1, 2030. The options have a ten-year term and were approved by the board under the 2018 Employment Inducement Incentive Award Plan. The company special...
07-02 11:05
VERAXA Biotech Initiates Cell Line Development with ATUM to Advance its Lead BiTAC®-TCE Program
VERAXA Biotech has partnered with ATUM to advance its lead BiTAC-TCE program using ATUM's Leap-In Transposase technology for stable clonal cell line generation, supporting IND/CTA-enabling activities. This collaboration aims to enhance the development of VERAXA's novel T-cell engager candidates, which use a dual-target, conditional-activation design to improve tumor selectivity and safety. Initial data from VERAXA's BiTAC-TCE program showed promi...
07-02 11:00
Carpenter Technology Announces Conference Call and Webcast
Carpenter Technology Corporation will host a conference call and webcast on July 30, 2026, at 10:00 a.m. ET to discuss its fourth-quarter fiscal 2026 results. The event will follow the release of its financial results before the market opens. The call can be accessed at +1 (646) 307-1963, and the webcast will be available live and archived at ir.carpentertechnology.com. Carpenter Technology is a leader in high-performance specialty alloys for var...
07-01 13:00
